Claudia Sheinbaum’s government is committed to mixed investment in the manufacture of vaccines and other pharmaceutical and doctors, so security and certainty to Mexican and foreign companies, said Sergio Iván Valdés Ferrer, director of scientific research in projects of projects of Health in the Ministry of Health (SSA).
“We are not afraid to approach the industry, external capital and philanthropy to give them comfort, security and certainty to invest together,” he said.
The plan is that the State and the industry can make mixed investments, since “we know that robust research needs all phases and all actors,” he said during the Nearshoring panel, health and innovation technology, carried out within the framework of the Health Summit: The Power of Innovation, an event organized by Forbes Mexico in alliance with Eli Lilly.
The government cannot do research only by seeing its small problems, because “much of the investigation comes from outside and its own investigation is required,” he said.
The administration of the health sector in Mexico is led by a giant, such as David Kershenobich Stallnikowitz, said the official.
“And that giant before becoming the Secretary of Health is a man who sweated clinical research,” he said.
Lee: Eli Lilly reaffirms your investment commitment in Mexico
“From that perspective, the Secretary of Health understands the needs and the health cabinet of the changes in clinical research for justice was informed from the beginning,” he said.
He said that among the government’s plans with the private initiative is the vaccine factory near Felipe Ángeles International Airport.
“From the Ministry of Health there is a plan so that in about 30 years there is a Nobel Prize,” he said.
Another of the government’s plans is that there are between 300 and 500 hubs where medical and pharmaceutical products are manufactured, he said.
“I hope Mexico attracts a small part of the 200 billion dollars, which are invested in clinical studies,” added Larry Rubin, executive director of the Mexican Association of Pharmaceutical Research Industries (AMIIF).
José Enrique Pérez Olguín, general director of the National Center for Technological Excellence in Health (CENENEC), commented that it will be invested in the development poles for well -being to detonate the medical and pharmaceutical industry in Mexico.
Yaneth Giha, executive director of the Latin American Federation of the Pharmaceutical Industry, said that the Governments of Latin America must invest in biotechnology to detonate economic development and growth.
“Science is global and international science,” added and explained that regulators’ training is necessary, as established by the Mexico Plan.
Patricia Clark, secretary of the General Health Council, said that for many years and decades “we have been working on the healing of diseases and detection of evils where the specialties participate.”
“Measurement protocols are documents that allow the guidelines of what are diagnostic prevention and the treatment of the most frequent diseases,” he said.
“We develop the protocols the methodology of the protocols and the methodology for diagnosis and treatment is defined through experts,” he said.
Do you like to inform yourself for Google News? Follow our showcase to have the best stories
